Blossom Limited established a share appreciation rights program that entitled its new president, Brandon Sutton, to receive cash for the difference between the shares' fair value and a pre-established price of $34 (also fair value on December 31, 2019), on 51,200 SARs. The date of grant is December 31, 2019, and the required employment (service) period is four years. The president exercised all of the SARS on December 31, 2024. The shares' fair value fluctuated as follows: December 31, 2020, $37; December 31, 2021, $41; December 31, 2022, $47; December 31, 2023, $37; and December 31, 2024, $50. The company recognizes the SARS in its financial statements. Assume that Blossom follows ASPE. (a) Prepare a five-year (2020 to 2024) schedule of compensation expense pertaining to the 51,200 SARs granted to Brandon Sutton. (Enter negative amounts using either a negative sign preceding the number e.g.-45 or parentheses e.g. (45).) Prepare a five-year (2020 to 2024) schedule of compensation expense pertaining to the 51,200 SARs granted to Brandon Sutton. (Enter negative amounts using either a negative sign preceding the number e.g. -45 or parentheses e.g. (45).) Schedule of Compensation Expense - Share Appreciation Rights (51,200) Fair Value Pre- established Price Cumulative Compensation Recognizable Percentage Accrued Compensa Accrued Date Date $ $ 12/31/20 $37 $34 % 12/31/21 41 34 % 12/31/22 47 34 % 12/31/23 37 34 % 12/31/24 50 34